Beyondspring Stock Price, News & Analysis (NASDAQ:BYSI)

$24.99 -0.91 (-3.51 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$25.90
Today's Range$24.99 - $26.15
52-Week Range$16.55 - $48.49
Volume9,934 shs
Average Volume3,643 shs
Market Capitalization$591.68 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Beyondspring (NASDAQ:BYSI)

Beyondspring logoBeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase II/III clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia, and a Phase III clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). Plinabulin has also entered in a Phase I/II clinical trials to investigate its therapeutic potential in combination with the immuno-oncology agent nivolumab. The Company's BPI-002 program is based on an oral small molecule agent, which induces T-cell activation. The Company's IkappaB kinase (IKK) program, BPI-003, is based on a small molecule inhibitor of IKK, a protein kinase.

Receive BYSI News and Ratings via Email

Sign-up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BYSI
CUSIPN/A
Phone646-528-4184

Debt

Debt-to-Equity RatioN/A
Current Ratio14.02%
Quick Ratio14.02%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees25
Outstanding Shares22,840,000

Beyondspring (NASDAQ:BYSI) Frequently Asked Questions

What is Beyondspring's stock symbol?

Beyondspring trades on the NASDAQ under the ticker symbol "BYSI."

How were Beyondspring's earnings last quarter?

Beyondspring Inc (NASDAQ:BYSI) issued its quarterly earnings data on Thursday, November, 9th. The company reported ($0.68) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.69) by $0.01. View Beyondspring's Earnings History.

When will Beyondspring make its next earnings announcement?

Beyondspring is scheduled to release their next quarterly earnings announcement on Friday, April, 27th 2018. View Earnings Estimates for Beyondspring.

Where is Beyondspring's stock going? Where will Beyondspring's stock price be in 2018?

4 equities research analysts have issued twelve-month price targets for Beyondspring's stock. Their predictions range from $50.00 to $60.00. On average, they expect Beyondspring's share price to reach $54.50 in the next year. View Analyst Ratings for Beyondspring.

What are Wall Street analysts saying about Beyondspring stock?

Here are some recent quotes from research analysts about Beyondspring stock:

  • 1. Maxim Group analysts commented, "On January 29th, BeyondSpring hosted a KOL call to discuss its lead asset, Plinabulin. Dr. Douglas Blayney, a founding member of the NCCN neutropenia management guideline panel, spoke on the call regarding Plinabulin and the ongoing phase 2/3 trial, Study 105 for the prevention of docetaxel chemotherapy-induced neutropenia (CIN)." (2/7/2018)
  • 2. According to Zacks Investment Research, "BeyondSpring Inc. is a clinical stage biopharmaceutical company. It focused on the development of cancer therapies. The Company's lead product consists of into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia. BeyondSpring Inc. is based in New York, United States. " (1/9/2018)

Who are some of Beyondspring's key competitors?

When did Beyondspring IPO?

(BYSI) raised $4 million in an initial public offering (IPO) on Thursday, March 9th 2017. The company issued 200,000 shares at a price of $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) acted as the underwriter for the IPO.

How do I buy Beyondspring stock?

Shares of Beyondspring can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Beyondspring's stock price today?

One share of Beyondspring stock can currently be purchased for approximately $24.99.

How big of a company is Beyondspring?

Beyondspring has a market capitalization of $591.68 million. Beyondspring employs 25 workers across the globe.

How can I contact Beyondspring?

Beyondspring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at 646-528-4184 or via email at [email protected]


MarketBeat Community Rating for Beyondspring (BYSI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  142
MarketBeat's community ratings are surveys of what our community members think about Beyondspring and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Beyondspring (NASDAQ:BYSI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $54.50$54.50$54.00$50.67
Price Target Upside: 109.53% upside87.22% upside52.76% upside31.91% upside

Beyondspring (NASDAQ:BYSI) Consensus Price Target History

Price Target History for Beyondspring (NASDAQ:BYSI)

Beyondspring (NASDAQ:BYSI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2018Maxim GroupReiterated RatingBuy$52.00LowView Rating Details
12/15/2017HC WainwrightSet Price TargetBuy$60.00HighView Rating Details
12/5/2017Seaport Global SecuritiesInitiated CoverageBuy -> Buy$56.00MediumView Rating Details
7/14/2017Rodman & RenshawBoost Price TargetBuy -> Buy$43.00 -> $50.00MediumView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Beyondspring (NASDAQ:BYSI) Earnings History and Estimates Chart

Earnings by Quarter for Beyondspring (NASDAQ:BYSI)

Beyondspring (NASDAQ BYSI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2018        
11/9/2017Q3 2017($0.69)($0.68)ViewN/AView Earnings Details
8/21/2017Q2 2017($0.24)($0.39)ViewN/AView Earnings Details
5/22/2017Q1 2017($0.27)($2.66)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Beyondspring (NASDAQ:BYSI) Earnings Estimates

Current Year EPS Consensus Estimate: $-4.41 EPS
Next Year EPS Consensus Estimate: $-3.71 EPS

Dividends

Dividend History for Beyondspring (NASDAQ:BYSI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Beyondspring (NASDAQ BYSI)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Beyondspring (NASDAQ BYSI) News Headlines

Source:
DateHeadline
BRIEF-BeyondSpring Says Richard Brand Resigned As CFOBRIEF-BeyondSpring Says Richard Brand Resigned As CFO
www.reuters.com - February 23 at 10:32 AM
Analysts Expect Beyondspring Inc (BYSI) to Announce ($0.76) Earnings Per ShareAnalysts Expect Beyondspring Inc (BYSI) to Announce ($0.76) Earnings Per Share
www.americanbankingnews.com - February 12 at 5:28 AM
Beyondspring (BYSI) Stock Rating Reaffirmed by Maxim GroupBeyondspring (BYSI) Stock Rating Reaffirmed by Maxim Group
www.americanbankingnews.com - February 7 at 8:36 AM
BeyondSpring to Present at Upcoming Investor ConferencesBeyondSpring to Present at Upcoming Investor Conferences
finance.yahoo.com - February 7 at 8:27 AM
BeyondSpring Summarizes Key Messages from KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced NeutropeniaBeyondSpring Summarizes Key Messages from KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia
finance.yahoo.com - February 5 at 5:05 PM
Zacks: Analysts Anticipate Beyondspring Inc (BYSI) Will Announce Earnings of -$0.76 Per ShareZacks: Analysts Anticipate Beyondspring Inc (BYSI) Will Announce Earnings of -$0.76 Per Share
www.americanbankingnews.com - January 30 at 7:10 PM
Zacks: Beyondspring Inc (BYSI) Given Average Rating of "Strong Buy" by BrokeragesZacks: Beyondspring Inc (BYSI) Given Average Rating of "Strong Buy" by Brokerages
www.americanbankingnews.com - January 28 at 9:30 PM
BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology SymposiumBeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
finance.yahoo.com - January 26 at 8:28 AM
Zacks: Beyondspring Inc (BYSI) Given Average Recommendation of "Strong Buy" by BrokeragesZacks: Beyondspring Inc (BYSI) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - January 25 at 3:30 PM
Zacks: Beyondspring Inc (BYSI) Receives Average Recommendation of "Strong Buy" from AnalystsZacks: Beyondspring Inc (BYSI) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - January 19 at 7:36 PM
BeyondSpring to Present Data from Phase 2 Portion of Study 105 Phase 2/3 Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical Immuno-Oncology SymposiumBeyondSpring to Present Data from Phase 2 Portion of Study 105 Phase 2/3 Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
finance.yahoo.com - January 17 at 8:55 AM
Zacks: Brokerages Expect Beyondspring Inc (BYSI) to Announce -$0.76 Earnings Per ShareZacks: Brokerages Expect Beyondspring Inc (BYSI) to Announce -$0.76 Earnings Per Share
www.americanbankingnews.com - January 13 at 9:36 PM
BeyondSpring to Present at the 10th Annual Biotech ShowcaseBeyondSpring to Present at the 10th Annual Biotech Showcase
finance.yahoo.com - January 5 at 9:12 AM
BRIEF-BeyondSpring Appoints Patrick Fabbio To Board As An Independent MemberBRIEF-BeyondSpring Appoints Patrick Fabbio To Board As An Independent Member
www.reuters.com - January 4 at 5:41 PM
Analysts Anticipate Beyondspring Inc (BYSI) to Announce ($0.76) Earnings Per ShareAnalysts Anticipate Beyondspring Inc (BYSI) to Announce ($0.76) Earnings Per Share
www.americanbankingnews.com - January 4 at 3:28 PM
BeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent MemberBeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent Member
finance.yahoo.com - January 3 at 8:19 AM
-$0.76 Earnings Per Share Expected for Beyondspring Inc (BYSI) This Quarter-$0.76 Earnings Per Share Expected for Beyondspring Inc (BYSI) This Quarter
www.americanbankingnews.com - December 28 at 3:21 AM
-$0.76 EPS Expected for Beyondspring Inc (BYSI) This Quarter-$0.76 EPS Expected for Beyondspring Inc (BYSI) This Quarter
www.americanbankingnews.com - December 28 at 3:21 AM
Financial Survey: Beyondspring (BYSI) and Its CompetitorsFinancial Survey: Beyondspring (BYSI) and Its Competitors
www.americanbankingnews.com - December 28 at 1:10 AM
Analysts Anticipate Beyondspring Inc (BYSI) to Announce ($0.76) EPSAnalysts Anticipate Beyondspring Inc (BYSI) to Announce ($0.76) EPS
www.americanbankingnews.com - December 20 at 10:20 PM
Beyondspring (BYSI) PT Set at $60.00 by HC WainwrightBeyondspring (BYSI) PT Set at $60.00 by HC Wainwright
www.americanbankingnews.com - December 15 at 12:04 PM
BRIEF-BeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with PlinabulinBRIEF-BeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with Plinabulin
www.reuters.com - December 15 at 9:26 AM
Beyondspring (BYSI) Receives "Buy" Rating from Maxim GroupBeyondspring (BYSI) Receives "Buy" Rating from Maxim Group
www.americanbankingnews.com - December 14 at 12:36 PM
BeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia (CIN)BeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia (CIN)
finance.yahoo.com - December 14 at 9:12 AM
Beyondspring (BYSI) and Its Competitors Financial ReviewBeyondspring (BYSI) and Its Competitors Financial Review
www.americanbankingnews.com - December 13 at 3:28 AM
BeyondSpring Inc. (BYSI) Forecasted to Post FY2017 Earnings of ($4.44) Per ShareBeyondSpring Inc. (BYSI) Forecasted to Post FY2017 Earnings of ($4.44) Per Share
www.americanbankingnews.com - December 8 at 7:32 AM
BeyondSpring to Webcast Key Opinion Leader Event in NYC on Dec. 14, 2017BeyondSpring to Webcast Key Opinion Leader Event in NYC on Dec. 14, 2017
finance.yahoo.com - December 7 at 9:09 AM
BeyondSpring (BYSI) Earns Buy Rating from Analysts at Seaport Global SecuritiesBeyondSpring (BYSI) Earns Buy Rating from Analysts at Seaport Global Securities
www.americanbankingnews.com - December 5 at 12:38 PM
Zacks: BeyondSpring Inc. (BYSI) Given $56.00 Average Price Target by BrokeragesZacks: BeyondSpring Inc. (BYSI) Given $56.00 Average Price Target by Brokerages
www.americanbankingnews.com - December 5 at 1:36 AM
HC Wainwright Reiterates "$60.00" Price Target for BeyondSpring (BYSI)HC Wainwright Reiterates "$60.00" Price Target for BeyondSpring (BYSI)
www.americanbankingnews.com - December 4 at 11:38 AM
BeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in ChinaBeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in China
finance.yahoo.com - December 4 at 9:02 AM
Zacks: BeyondSpring Inc. (BYSI) Receives Consensus Rating of "Strong Buy" from BrokeragesZacks: BeyondSpring Inc. (BYSI) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - December 1 at 3:50 PM
BeyondSpring (BYSI) Given a $52.00 Price Target at Maxim GroupBeyondSpring (BYSI) Given a $52.00 Price Target at Maxim Group
www.americanbankingnews.com - November 30 at 7:34 PM
BRIEF-Beyondspring Says Initiates Global Phase 2/3 Trial With Plinabulin In ChinaBRIEF-Beyondspring Says Initiates Global Phase 2/3 Trial With Plinabulin In China
www.reuters.com - November 30 at 5:40 PM
BeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate SuperiorityBeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority
finance.yahoo.com - November 30 at 5:40 PM
 BeyondSpring Inc. (BYSI) Given $56.00 Average Target Price by Brokerages BeyondSpring Inc. (BYSI) Given $56.00 Average Target Price by Brokerages
www.americanbankingnews.com - November 15 at 5:06 AM
BeyondSpring Inc. (BYSI) Lowered to "Sell" at Zacks Investment ResearchBeyondSpring Inc. (BYSI) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - November 13 at 8:30 PM
BeyondSpring Inc. (BYSI) Posts Quarterly  Earnings Results, Beats Expectations By $0.01 EPSBeyondSpring Inc. (BYSI) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - November 10 at 12:51 PM
BeyondSpring Reports Third Quarter 2017 Operational and Financial ResultsBeyondSpring Reports Third Quarter 2017 Operational and Financial Results
finance.yahoo.com - November 9 at 6:16 PM
Zacks: BeyondSpring Inc. (BYSI) Receives Consensus Rating of "Strong Buy" from AnalystsZacks: BeyondSpring Inc. (BYSI) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - November 9 at 11:46 AM
BeyondSpring Inc. (BYSI) Set to Announce Quarterly Earnings on ThursdayBeyondSpring Inc. (BYSI) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - November 3 at 10:59 AM
BeyondSpring to Host Quarterly Operational Update Conference Call on November 9, 2017BeyondSpring to Host Quarterly Operational Update Conference Call on November 9, 2017
finance.yahoo.com - November 2 at 5:34 PM
BeyondSpring Announces the First Patient Enrolled in China in its Global Phase 2/3 Trial with Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaBeyondSpring Announces the First Patient Enrolled in China in its Global Phase 2/3 Trial with Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia
finance.yahoo.com - October 26 at 8:48 AM
HC Wainwright Boosts BeyondSpring Inc. (BYSI) Price Target to $60.00HC Wainwright Boosts BeyondSpring Inc. (BYSI) Price Target to $60.00
www.americanbankingnews.com - October 26 at 7:38 AM
BeyondSpring Receives Two Grants in China to Further Develop Innovative Drug PipelineBeyondSpring Receives Two Grants in China to Further Develop Innovative Drug Pipeline
finance.yahoo.com - October 23 at 5:44 PM
BeyondSpring Becomes Oversold (BYSI)BeyondSpring Becomes Oversold (BYSI)
www.thestreet.com - October 20 at 11:39 PM
BeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San FranciscoBeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San Francisco
feeds.benzinga.com - October 18 at 8:55 AM
-$0.69 Earnings Per Share Expected for BeyondSpring Inc. (BYSI) This Quarter-$0.69 Earnings Per Share Expected for BeyondSpring Inc. (BYSI) This Quarter
www.americanbankingnews.com - September 26 at 10:10 AM
BeyondSpring Looks to Future After IPO/PIPE LaunchBeyondSpring Looks to Future After IPO/PIPE Launch
finance.yahoo.com - September 15 at 10:17 PM
BeyondSpring (BYSI) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowBeyondSpring (BYSI) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 13 at 11:02 PM

SEC Filings

Beyondspring (NASDAQ:BYSI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Beyondspring (NASDAQ:BYSI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Beyondspring (NASDAQ BYSI) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.